Search - tctmd.com

Displaying 361 - 380 of 635

Sort: Relevancy | Date

$Aortic Watchman As Centinel for Thrombus Embolization in Patient With Recurrent Lower Gastrointestinal Bleeding and Refractory Thrombus in LAA$

Presentation The Structural Heart Disease Summit 2018

Aortic Watchman As Centinel for Thrombus Embolization in Patient With Recurrent Lower Gastrointestinal Bleeding and Refractory Thrombus in LAA

Presenter: Horst Sievert, Robert J. Sommer, Luis Gutierrez, MD

June 22, 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

Presentation The Structural Heart Disease Summit 2018

The PORTICO TAVR System: Illustrative Cases (Eg, Low Coronaries)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

Minimizing Left Ventricular Outflow Tract Obstruction in “Valve-in-Mitral” Cases: A Novel Technique

Presentation The Structural Heart Disease Summit 2018

Minimizing Left Ventricular Outflow Tract Obstruction in Valve-in-Mitral Cases: A Novel Technique

Presenter: Juan F. Granada, Martin B. Leon, Tarek Helmy

June 22, 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The PORTICO TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Raj Makkar

June 22, 2018

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

The LOTUS TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presentation The Structural Heart Disease Summit 2018

The LOTUS Edge TAVR System: Illustrative Cases (Eg, Extreme Calcification, Bicuspid Valves)

Presenter: Axel Linke, Vinod H. Thourani, John K. Forrest, Fabian Nietlispach, Jeffrey J. Popma, Mark J. Russo, Torsten P. Vahl, Jonathon M. White, Mathew Williams

June 22, 2018

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Presentation The Structural Heart Disease Summit 2018

TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples)

Presenter: Howard C. Herrmann, Allan Schwartz, Eberhard Grube

June 22, 2018

Program Update: The LOTUS TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Ted Feldman

June 22, 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presentation The Structural Heart Disease Summit 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo

June 22, 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presentation The Structural Heart Disease Summit 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presenter: Francesco Maisano

June 22, 2018

Who Shouldn't Undergo TAVR? Can We Identify the ‘Futile' Non-responders?

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Presentation The Structural Heart Disease Summit 2018

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Presenter: David A. Wood

June 22, 2018

Conductor (Illustrative Cases)

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: Tamim Nazif

June 22, 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of “Watchful Waiting” in Managing Asymptomatic Patients With Severe AS

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, John G. Webb

June 22, 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presenter: David J. Cohen

June 22, 2018

Status Update of the EARLY TAVR Trial – Asymptomatic Severe AS Patients

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Status Update of the TAVR UNLOAD Trial – Moderate AS Patients With Reduced Ejection Fraction

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.